Compounds > phorbol 12,13-dibutyrate
Page last updated: 2024-08-23

phorbol 12,13-dibutyrate and Head and Neck Neoplasms

phorbol 12,13-dibutyrate has been researched along with Head and Neck Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Basu, A; Saijo, N; Weixel, K1
Freeman, JW; Hamby, LS; McGrath, PC1
Basu, A; Lazo, JS1

Other Studies

3 other study(ies) available for phorbol 12,13-dibutyrate and Head and Neck Neoplasms

ArticleYear
Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells.
    Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1996, Volume: 7, Issue:11

    Topics: Antineoplastic Agents; Bleomycin; Bryostatins; Carcinoma; Carcinoma, Small Cell; Cisplatin; Drug Resistance, Neoplasm; Enzyme Activation; Etoposide; Female; Head and Neck Neoplasms; Herpes Simplex Virus Protein Vmw65; Humans; Lactones; Lung Neoplasms; Macrolides; Ovarian Neoplasms; Paclitaxel; Phorbol 12,13-Dibutyrate; Protein Kinase C; Signal Transduction; Tumor Cells, Cultured

1996
Phorbol dibutyrate plus ionomycin improves the generation of cytotoxic T cells from draining lymph nodes of patients with advanced head and neck cancer.
    American journal of surgery, 1992, Volume: 164, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Division; Cytotoxicity Tests, Immunologic; Head and Neck Neoplasms; Humans; Immunotherapy, Adoptive; Ionomycin; Lymph Nodes; Lymphatic Metastasis; Lymphocyte Activation; Phorbol 12,13-Dibutyrate; T-Lymphocytes, Cytotoxic; Tumor Cells, Cultured

1992
Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1.
    Cancer research, 1992, Jun-01, Volume: 52, Issue:11

    Topics: Antineoplastic Agents; Biological Transport; Bryostatins; Cell Division; Cell Line; Cisplatin; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Activation; Head and Neck Neoplasms; HeLa Cells; Humans; Isoenzymes; Kinetics; Lactones; Macrolides; Organoplatinum Compounds; Phorbol 12,13-Dibutyrate; Protein Kinase C; Tetradecanoylphorbol Acetate; Time Factors

1992